Eli Lilly's third quarter earnings miss and forecast cut lead to sharp stock drop

Michigan City News Dispatch

Oct 30, 2024

Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two key drugs that missed expectations. The drugmaker on Wedn…